Cargando…
Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients
Objective: Atrial fibrillation (AF) and venous thromboembolism (VTE) share several risk factors related to arterial thromboembolism. No study has reported the differential contribution to arterial thromboembolic events and mortality between these two conditions in the same population. We therefore a...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685417/ https://www.ncbi.nlm.nih.gov/pubmed/34938791 http://dx.doi.org/10.3389/fcvm.2021.775564 |
_version_ | 1784617831076200448 |
---|---|
author | Lin, Yu-Sheng Lin, Ming-Shyan Wu, Victor Chien-Chia Chen, Yung-Lung Chang, Jung-Jung Chu, Pao-Hsien Lip, Gregory Y. H. Chen, Mien-Cheng |
author_facet | Lin, Yu-Sheng Lin, Ming-Shyan Wu, Victor Chien-Chia Chen, Yung-Lung Chang, Jung-Jung Chu, Pao-Hsien Lip, Gregory Y. H. Chen, Mien-Cheng |
author_sort | Lin, Yu-Sheng |
collection | PubMed |
description | Objective: Atrial fibrillation (AF) and venous thromboembolism (VTE) share several risk factors related to arterial thromboembolism. No study has reported the differential contribution to arterial thromboembolic events and mortality between these two conditions in the same population. We therefore assessed the differential arterial thromboembolic events between AF and VTE. Methods: We included AF and VTE national cohorts derived from Taiwan National Health Insurance Research Database between 2001 and 2013. The eligible population was 314,861 patients in the AF cohort and 41,102 patients in the VTE cohort. The primary outcome was arterial thromboembolic events, including ischemic stroke, extracranial arterial thromboembolism (ECATE) and myocardial infarction (MI). Secondary outcomes were all-cause mortality and cardiovascular death. Results: After a 1:1 propensity matching, 32,688 patients in either group were analyzed. The risk of arterial thromboembolic events was lower in the VTE cohort than that in the AF cohort (subdistribution hazard ratio [SHR], 0.60; 95% confidence interval [CI], 0.57–0.62). The risk of ischemic stroke (SHR, 0.44; 95% CI, 0.42–0.46) and MI (SHR, 0.80; 95% CI, 0.72–0.89) were lower in the VTE cohort, while the risk of ECATE (SHR, 1.23; 95% CI, 1.14–1.33; particularly lower extremities) was higher in the VTE cohort. All-cause mortality rate was higher in the VTE cohort (HR, 1.18; 95% CI, 1.15–1.21) while the risk of cardiovascular death was lower in the VTE cohort (HR, 0.96; 95% CI, 0.93–0.995). Conclusions: Patients with AF had higher risks of arterial thromboembolic events compared to patients with VTE, despite having risk factors in common. The VTE cohort had higher risks of all-cause mortality and ECATE, particularly lower extremity events, compared to AF patients. The differential manifestations of thromboembolism sequelae and mortality between AF and VTE patients merit further investigation. |
format | Online Article Text |
id | pubmed-8685417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86854172021-12-21 Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients Lin, Yu-Sheng Lin, Ming-Shyan Wu, Victor Chien-Chia Chen, Yung-Lung Chang, Jung-Jung Chu, Pao-Hsien Lip, Gregory Y. H. Chen, Mien-Cheng Front Cardiovasc Med Cardiovascular Medicine Objective: Atrial fibrillation (AF) and venous thromboembolism (VTE) share several risk factors related to arterial thromboembolism. No study has reported the differential contribution to arterial thromboembolic events and mortality between these two conditions in the same population. We therefore assessed the differential arterial thromboembolic events between AF and VTE. Methods: We included AF and VTE national cohorts derived from Taiwan National Health Insurance Research Database between 2001 and 2013. The eligible population was 314,861 patients in the AF cohort and 41,102 patients in the VTE cohort. The primary outcome was arterial thromboembolic events, including ischemic stroke, extracranial arterial thromboembolism (ECATE) and myocardial infarction (MI). Secondary outcomes were all-cause mortality and cardiovascular death. Results: After a 1:1 propensity matching, 32,688 patients in either group were analyzed. The risk of arterial thromboembolic events was lower in the VTE cohort than that in the AF cohort (subdistribution hazard ratio [SHR], 0.60; 95% confidence interval [CI], 0.57–0.62). The risk of ischemic stroke (SHR, 0.44; 95% CI, 0.42–0.46) and MI (SHR, 0.80; 95% CI, 0.72–0.89) were lower in the VTE cohort, while the risk of ECATE (SHR, 1.23; 95% CI, 1.14–1.33; particularly lower extremities) was higher in the VTE cohort. All-cause mortality rate was higher in the VTE cohort (HR, 1.18; 95% CI, 1.15–1.21) while the risk of cardiovascular death was lower in the VTE cohort (HR, 0.96; 95% CI, 0.93–0.995). Conclusions: Patients with AF had higher risks of arterial thromboembolic events compared to patients with VTE, despite having risk factors in common. The VTE cohort had higher risks of all-cause mortality and ECATE, particularly lower extremity events, compared to AF patients. The differential manifestations of thromboembolism sequelae and mortality between AF and VTE patients merit further investigation. Frontiers Media S.A. 2021-12-06 /pmc/articles/PMC8685417/ /pubmed/34938791 http://dx.doi.org/10.3389/fcvm.2021.775564 Text en Copyright © 2021 Lin, Lin, Wu, Chen, Chang, Chu, Lip and Chen. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Lin, Yu-Sheng Lin, Ming-Shyan Wu, Victor Chien-Chia Chen, Yung-Lung Chang, Jung-Jung Chu, Pao-Hsien Lip, Gregory Y. H. Chen, Mien-Cheng Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title | Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title_full | Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title_fullStr | Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title_full_unstemmed | Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title_short | Differential Presentations of Arterial Thromboembolic Events Between Venous Thromboembolism and Atrial Fibrillation Patients |
title_sort | differential presentations of arterial thromboembolic events between venous thromboembolism and atrial fibrillation patients |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685417/ https://www.ncbi.nlm.nih.gov/pubmed/34938791 http://dx.doi.org/10.3389/fcvm.2021.775564 |
work_keys_str_mv | AT linyusheng differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT linmingshyan differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT wuvictorchienchia differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT chenyunglung differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT changjungjung differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT chupaohsien differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT lipgregoryyh differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients AT chenmiencheng differentialpresentationsofarterialthromboemboliceventsbetweenvenousthromboembolismandatrialfibrillationpatients |